Benefit of Bovine or Marine Collagen Vs. Placebo on Skin, Hair, Nails and Whole Body Health in Healthy Adults (BECOME)

Ancient + Brave

Status: Enrolling

Conditions: Hair Thinning; Nails; Skin Laxity

Treatments: Dietary Supplement: Bovine or Marine Collagen

Study type: Interventional

Funder types: Industry; Other

Identifiers

NCT06603194

AABVIV1C

Details and patient eligibility

About

The BECOME Study (Bovine and Marine Collagen Efficacy for Skin, Hair, Nails and Whole Body Health Markers Evaluation) is a randomized controlled trial designed to compare the effects of bovine and marine collagen supplements versus a placebo on skin, hair, nails and whole body health markers. The trial aims to determine the most efficacious collagen source for improving health outcomes and to establish if both types of collagen are equally effective. Participants will be assessed on various health parameters, including skin elasticity, joint health, digestive health, and overall well-being, over a specified period.

Enrollment: 90 estimated patients

Sex: Female

Ages: 35 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Females aged 35-55 years. Participants must be comfortable with bovine or marine collagen (non-vegan/vegetarian).

Must provide informed consent and be willing to comply with study requirements.

Exclusion criteria

Pregnant or breastfeeding women. History of chronic skin conditions (e.g., eczema, psoriasis) that might interfere with study outcomes.

Any active skin infections or severe acne. Currently taking collagen supplements or have taken them within the last 6 months.

Use of medications or topical agents that can affect skin, hair, nails, or gastrointestinal health (e.g., corticosteroids, retinoids).

Excessive alcohol consumption or current smokers. Regular use of sunbeds. Recent cosmetic procedures (e.g., Botox, fillers, chemical peels, laser treatments) on skin, hair, or nails within the last 3 months.

Any condition or situation that, in the opinion of the investigator, may interfere with the participant's ability to comply with the study requirements or give informed consent.

Poor adherence to previous study protocols

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

90 participants in 3 patient groups, including a placebo group

Bovine Collagen

Active Comparator group

Description:

10g powder format taken daily for duration of the study.

Treatment:

Dietary Supplement: Bovine or Marine Collagen

Marine Collagen

Active Comparator group

Description:

10g powder format taken daily for duration of the study.

Treatment:

Dietary Supplement: Bovine or Marine Collagen

Placebo

Placebo Comparator group

Treatment:

Dietary Supplement: Bovine or Marine Collagen